Formulation of Microneedles Coated with Influenza Virus-like Particle Vaccine
暂无分享,去创建一个
Yeu-Chun Kim | M. Prausnitz | R. Compans | F. Quan | Yeu‐Chun Kim | Sang-Moo Kang | Fu-Shi Quan | Sang-Moo Kang | Mark R. Prausnitz | Richard W. Compans
[1] P. Thongcharoen,et al. Antibody responses after dose-sparing intradermal influenza vaccination. , 2007, Vaccine.
[2] R. Compans,et al. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. , 2006, Vaccine.
[3] A. Palache. Influenza vaccines. A reappraisal of their use. , 1997, Drugs.
[4] K. Nichol,et al. Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.
[5] G. Vyas,et al. Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis , 1970, Science.
[6] F. de Looze,et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. , 2008, The Journal of infectious diseases.
[7] A. Morrissey,et al. Clinical administration of microneedles: skin puncture, pain and sensation , 2009, Biomedical microdevices.
[8] M. Prausnitz,et al. Improved influenza vaccination in the skin using vaccine coated microneedles. , 2009, Vaccine.
[9] Michel Cormier,et al. Microneedle-based vaccines. , 2009, Current topics in microbiology and immunology.
[10] L. Babiuk,et al. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization , 2009, Proceedings of the National Academy of Sciences.
[11] M. Ameri,et al. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. , 2004, Journal of pharmaceutical sciences.
[12] R. Compans,et al. Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization , 2007, Journal of Virology.
[13] Mark R. Prausnitz,et al. Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.
[14] M. Prausnitz,et al. Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays , 2009, PLoS ONE.
[15] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[16] J. Stockman. Serum Antibody Responses After Intradermal Vaccination Against Influenza , 2006 .
[17] M. Prausnitz,et al. Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin , 2009, PloS one.
[18] R. Compans,et al. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. , 2008, Vaccine.
[19] J. Stockman. Dose Sparing With Intradermal Injection of Influenza Vaccine , 2006 .
[20] Walter A Orenstein,et al. Vaccine shortages: history, impact, and prospects for the future. , 2006, Annual review of public health.
[21] M. Prausnitz,et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge , 2009, Proceedings of the National Academy of Sciences.
[22] R. Compans,et al. Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus , 2007, Journal of Virology.
[23] R. Ghohestani,et al. Immune functions of the skin. , 2001, Clinics in dermatology.
[24] A. Herrmann,et al. Analysis of delay times of hemagglutinin-mediated fusion between influenza virus and cell membranes , 2004, European Biophysics Journal.
[25] J. Bouwstra,et al. In vivo assessment of safety of microneedle arrays in human skin. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[26] W. Hinrichs,et al. The development of stable influenza vaccine powder formulations for new needle-free dosage forms , 2017 .
[27] Michael S Roberts,et al. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[28] P. van Damme,et al. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. , 2009, Vaccine.
[29] W. Hinrichs,et al. Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities , 2008, Pharmaceutical Research.
[30] M. Prausnitz,et al. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. , 2010, The Journal of infectious diseases.
[31] P. Lambert,et al. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? , 2008, Vaccine.
[32] P. Roy,et al. Virus-like particles as immunogens. , 2003, Trends in microbiology.
[33] Mark R Prausnitz,et al. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[34] W. Hinrichs,et al. Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] S. Sambhara,et al. Vaccines against epidemic and pandemic influenza , 2008 .
[36] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[37] C. Gerdil. The annual production cycle for influenza vaccine. , 2003, Vaccine.
[38] R. J. Webby,et al. Influenza vaccines. , 2009, Vaccine.
[39] D. Steinhauer,et al. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. , 1999, Virology.
[40] Mark R Prausnitz,et al. Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[41] Martin F. Bachmann,et al. The coming of age of virus-like particle vaccines , 2008, Biological chemistry.